🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to evaluate the safety, tolerability and immunogenicity of a ...
Status
Completed
Location
Daido Clinic
Start Date
2018-07-12
Trial ID
NCT03571607
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00366899
Treatments Being Tested
The purpose of this study is to assess the "late" immune response to furthe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-01
Trial ID
NCT00824850
Treatments Being Tested
This study is designed to assess the impact of 13-valent Pneumococcal Conju...
Status
Completed
Location
Pfizer Investigational Sites (7)
Start Date
2007-12
Trial ID
NCT00508742
Treatments Being Tested
Prevnar (7 valent pneumococcal conjugate vaccine \[7vPnC\]) has been shown ...
Status
Completed
Location
Penfield Pediatrics
Start Date
2010-09
Trial ID
NCT01199016
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability and immunog...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-06
Trial ID
NCT00689351
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00373958
Treatments Being Tested
The purpose of this study is to assess the safety and immunogenicity of 13-...
Status
Completed
Location
Huaiyin District Center for Disease Prevention and Control
Start Date
2018-06-23
Trial ID
NCT03574389
This study is to describe the safety and immunogenicity of 13vPnC in Indian...
Status
Completed
Location
King George Hospital
Start Date
2014-08
Trial ID
NCT02034877
Treatments Being Tested
This is an open-label study (a study in which the doctors and participants ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01026038
Treatments Being Tested